the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Salah suggests he will be at Liverpool next season

LIVERPOOL forward Mohamed Salah has suggested he will stay at the Premier League club following the departure of manager Juergen Klopp, the Egypt international said late on Monday.

With Klopp’s exit after nearly nine years at the helm and Feyenoord coach Arne Slot officially confirmed as his successor, uncertainties regarding Salah’s future at Liverpool had grown, with his contract expiring in June 2025.

The 31-year-old has been linked with a move to the Saudi Arabian league during the close season. Liverpool’s top scorer this season appeared somewhat out of form, especially towards the end of the campaign when their title charge faltered.

Late on Monday, after Slot was announced as Liverpool’s new coach, Salah set forth his side’s ambitions for the next season and sent out a parting message for Klopp.

“We know that trophies are what count and we will do everything possible to make that happen next season.” Salah wrote in a post on social media. “Our fans deserve it and we will fight like hell.”

“It was great sharing all those trophies and experiences with you over the past 7 years,“ Salah captioned a picture of himself with the former Liverpool manager. “I wish you the best of luck for the future and hope we meet again.”

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings